| Dr Simon Paul Drew, MD | |
|
140 Hospital Dr, Ste 203, Bennington, VT 05201-5015 | |
| (802) 442-3800 | |
| (802) 447-0635 |
| Full Name | Dr Simon Paul Drew |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 140 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548266893 | NPI | - | NPPES |
| 1010955 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 042-0010815 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwestern Vermont Medical Center Inc | 0143138446 | 142 |
News Archive
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Although tests carried out by biosafety experts in Britain have revealed the strain of foot and mouth disease found in cattle is the same as that used in vaccine production at a nearby animal health research facility, no apparent breach of biosecurity measures has been found.
Several articles published on Tuesday examine tuberculosis (TB) in South Africa. "According to the World Health Organization (WHO), the country has the highest rate of new TB cases annually," VOA News writes, adding, "Thousands of people in South Africa continue to be infected by a disease that's been virtually eradicated in the developed world."
Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Progression of disease, which can precede cancer, was rare in patients who underwent RFA treatment, and there was no procedure- or cancer-related mortality.
› Verified 9 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Although tests carried out by biosafety experts in Britain have revealed the strain of foot and mouth disease found in cattle is the same as that used in vaccine production at a nearby animal health research facility, no apparent breach of biosecurity measures has been found.
Several articles published on Tuesday examine tuberculosis (TB) in South Africa. "According to the World Health Organization (WHO), the country has the highest rate of new TB cases annually," VOA News writes, adding, "Thousands of people in South Africa continue to be infected by a disease that's been virtually eradicated in the developed world."
Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Progression of disease, which can precede cancer, was rare in patients who underwent RFA treatment, and there was no procedure- or cancer-related mortality.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Simon Paul Drew, MD 140 Hospital Dr, Ste 203, Bennington, VT 05201-5015 Ph: (802) 442-3800 | Dr Simon Paul Drew, MD 140 Hospital Dr, Ste 203, Bennington, VT 05201-5015 Ph: (802) 442-3800 |
News Archive
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Although tests carried out by biosafety experts in Britain have revealed the strain of foot and mouth disease found in cattle is the same as that used in vaccine production at a nearby animal health research facility, no apparent breach of biosecurity measures has been found.
Several articles published on Tuesday examine tuberculosis (TB) in South Africa. "According to the World Health Organization (WHO), the country has the highest rate of new TB cases annually," VOA News writes, adding, "Thousands of people in South Africa continue to be infected by a disease that's been virtually eradicated in the developed world."
Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Progression of disease, which can precede cancer, was rare in patients who underwent RFA treatment, and there was no procedure- or cancer-related mortality.
› Verified 9 days ago
Robert Anthony Pezzulich, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 345 Elm St, Bennington, VT 05201 Phone: 802-447-7591 Fax: 802-447-3858 | |
Frederick P. Loy, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 140 Hospital Dr, Medical Building, Bennington, VT 05201 Phone: 802-447-0607 Fax: 802-447-0608 | |
Dr. Charles Henry Salem, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 345 Elm St, Bennington, VT 05201 Phone: 802-447-7591 Fax: 802-447-3858 | |
Graham J Moore, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr, Suite 203, Bennington, VT 05201 Phone: 802-442-3800 Fax: 802-442-3855 | |
Gina Diaz Lamb, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Drive, Suite 205, Bennington, VT 05201 Phone: 802-447-5060 | |
Elizabeth Ellen Warner, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 140 Hospital Dr, Suite 203, Bennington, VT 05201 Phone: 802-442-3800 |